These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6776666)

  • 41. Trypanosoma brucei: trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats.
    Van Der Meer C; Versluijs-Broers JA
    Exp Parasitol; 1979 Aug; 48(1):126-34. PubMed ID: 456462
    [No Abstract]   [Full Text] [Related]  

  • 42. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rational concepts and the study of active molecules against various trypanosomiases].
    Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
    Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
    Bouteille B; Darde ML; Pestre-Alexandre M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetoplasts play an important role in the drug responses of Trypanosoma brucei.
    Agbe A; Yielding KL
    J Parasitol; 1995 Dec; 81(6):968-73. PubMed ID: 8544073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trypanosoma brucei: biochemical and morphological changes during in vitro transformation of bloodstream- to procyclic-trypomastigotes.
    Bienen EJ; Hammadi E; Hill GC
    Exp Parasitol; 1981 Jun; 51(3):408-17. PubMed ID: 6785103
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
    Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo trypanocidal activity of Annona senegalensis Pers. leaf extract against Trypanosoma brucei brucei.
    Ogbadoyi EO; Abdulganiy AO; Adama TZ; Okogun JI
    J Ethnopharmacol; 2007 May; 112(1):85-9. PubMed ID: 17418511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Kaminsky R
    Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semicarbazide-sensitive amine oxidase kills African trypanosomes in vitro.
    Wang QP; Lai DH; Li Z; Li FJ; Lun ZR
    Acta Trop; 2011 Feb; 117(2):161-4. PubMed ID: 21145304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Miconazole in coccidioidomycosis. I. Assays of activity in mice and in vitro.
    Levine HB; Stevens DA; Cobb JM; Gebhardt AE
    J Infect Dis; 1975 Oct; 132(4):407-14. PubMed ID: 1185010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do we need new drugs against human African trypanosomiasis?
    Stich A; Ponte-Sucre A; Holzgrabe U
    Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207
    [No Abstract]   [Full Text] [Related]  

  • 56. New approach to screening drugs for activity against African trypanosomes.
    Fairlamb AH; Opperdoes FR; Borst P
    Nature; 1977 Jan; 265(5591):270-1. PubMed ID: 834274
    [No Abstract]   [Full Text] [Related]  

  • 57. Glycerol, a possible new player in the biology of trypanosomes.
    Bringaud F; Plazolles N; Pineda E; Asencio C; Villafraz O; Millerioux Y; Rivière L; Tetaud E
    PLoS Pathog; 2021 Dec; 17(12):e1010035. PubMed ID: 34855923
    [No Abstract]   [Full Text] [Related]  

  • 58. Antimycotic activity of miconazole (R 18134) in vitro and in vivo.
    Costa AL; Valenti A; Loteta LE; Midili S
    Mykosen; 1977 Nov; 20(11):431-40. PubMed ID: 593299
    [No Abstract]   [Full Text] [Related]  

  • 59. Solubilization and partial purification of glycerol-3-phosphate oxidase from mitochondria of Trypanosoma brucei.
    Bass HS; Njogu RM; Hill GC
    Exp Parasitol; 1990 May; 70(4):486-9. PubMed ID: 2323400
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of dietary pyridoxine on infections of Trypanosoma brucei brucei in mice.
    Kilgour V; Godfrey DG
    Trans R Soc Trop Med Hyg; 1973; 67(2):258. PubMed ID: 4784067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.